Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
source: pixabay.com

Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma

According to a story from BioSpace, the U.S. Food and Drug Administration has given Fast Track designation for nintedanib, which is undergoing testing for the treatment of systemic sclerosis with…

Continue Reading Nintedanib Gets Fast Track Designation for the Treatment of Scleroderma
No-Cost Disease Diagnosis and Immunoglobulin Therapies Now Available to Children with Primary Immunodeficiency Diseases
Source: Pixabay

No-Cost Disease Diagnosis and Immunoglobulin Therapies Now Available to Children with Primary Immunodeficiency Diseases

Primary immunodeficiency diseases account for hundreds of rare and chronic diseases. In children, this may mean that their immune system is non-existent or doesn't perform as expected. To learn more…

Continue Reading No-Cost Disease Diagnosis and Immunoglobulin Therapies Now Available to Children with Primary Immunodeficiency Diseases
The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from raredr.com, The U.S. Food and Drug Administration (FDA) has recently approved Hizentra as a maintenance therapy for patients with chronic inflammatory demyelinating polyneuropathy. Hizentra is…

Continue Reading The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
source: pixabay.com

The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy

According to a story from raredr.com, the FDA had to order the cessation of Phase II/III trials for the microdystrophin transfer therapy SGT-001, which was in development for the treatment…

Continue Reading The FDA Puts a Halt to Trial for SGT-001, A Treatment in Development for Duchenne Muscular Dystrophy
New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans
Source: Pixabay

New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans

A team lead by geneticist Christopher Gregg from the University of Utah conducted a study on elephant genes that discovered why elephants don't get cancer, reported by News 4 Tucson.…

Continue Reading New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans
UK Family Travels to The Netherlands To Find Treatment For Their Daughter With Dravet Syndrome
Source: Pixabay

UK Family Travels to The Netherlands To Find Treatment For Their Daughter With Dravet Syndrome

According to BelfastLive, Darren and Danielle Gibson, the parents of little six-year-old Sophia battling Dravet syndrome, traveled out of the country in search of the care she needs. For the…

Continue Reading UK Family Travels to The Netherlands To Find Treatment For Their Daughter With Dravet Syndrome
Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis
source: pixabay.com

Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis

According to a story from drugs.com, kids and teenagers with chronic kidney disease (CKD) may develop problems with learning and cognition, a new study suggests. Researchers emphasize that patients on…

Continue Reading Children with Chronic Kidney Disease May Have Learning Problems Because of Dialysis
New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients
Source: Pixabay

New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients

Novartis and Pear Therapeutics have joined forces to develop digital therapeutic software applications to treat patients with schizophrenia and multiple sclerosis, reports World Pharma News. Novartis is known for the…

Continue Reading New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients
This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis
RobinHiggins / Pixabay

This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis

According to a story from Medical Xpress, the addition of crizotinib with radiation therapy could help reduce hearing loss associated with the treatment in patients with neurofibromatosis II. Crizotinib is…

Continue Reading This Cancer Drug May Reduce Hearing Loss From Radiotherapy In Patients With Neurofibromatosis
After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment
source: pixabay.com

After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment

According to a story from the Vancouver Sun, 11-year-old Jaylene Prime from British Columbia was able to obtain access to a critical treatment for her juvenile idiopathic arthritis. The drug,…

Continue Reading After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment
Two Thirds of Pancreatic Cancer Patients Don’t Receive Needed Treatments. Why?
Source: Pixabay

Two Thirds of Pancreatic Cancer Patients Don’t Receive Needed Treatments. Why?

The Southern Daily Echo originally reported that a majority of pancreatic cancer patients don't receive life-extending treatment after diagnosis. Recently, the Pancreatic Cancer UK charity reported that only a small…

Continue Reading Two Thirds of Pancreatic Cancer Patients Don’t Receive Needed Treatments. Why?
A Drug That Can Mimic Exercise May Be Closer Than You Thought
Source: Pixabay

A Drug That Can Mimic Exercise May Be Closer Than You Thought

Scientists in California at Salk Institute for Biological Studies are currently developing a drug that can mimic the effects in the body usually obtained from exercise, reports the National Post.…

Continue Reading A Drug That Can Mimic Exercise May Be Closer Than You Thought
A Unique Experimental Treatment Just Got Orphan Drug Designation for Huntington’s Disease
source: pixabay.com

A Unique Experimental Treatment Just Got Orphan Drug Designation for Huntington’s Disease

According to a story from Morningstar, the pharmaceutical company Emerald Health Pharmaceuticals announced that its drug candidate EHP-102 was given Orphan Drug Designation by the U.S Food and Drug Administration…

Continue Reading A Unique Experimental Treatment Just Got Orphan Drug Designation for Huntington’s Disease
Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan
source: pixabay.com

Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan

The day after Christmas in 2016 brought a post-Holiday surprise to many in the U.S. with spinal muscular atrophy. December 26, 2016 marked the day that Spinraza was approved by…

Continue Reading Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan